China Pharma announces 1-for-5 reverse stock split effective March 6, 2024

CHINA PHARMA HOLDINGS, INC.

Reverse split at 1-for-5 ratio, effective March 6, 2024; every 5 pre-split shares convert to 1 post-split share.
No fractional shares issued; any fractional shares will be rounded up to the next whole number.
Trading continues on NYSE American under symbol CPHI; new CUSIP is 16941T 302.
Split approved by Board on Oct 16, 2023 and by stockholders on Dec 17, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.